Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
2017 · Science Signaling · 299 citations
https://doi.org/10.1126/scisignal.aam7479
Y
Yong Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
1.3K
Citations
17
h-index
20
i10-index
Yong Luo is an academic researcher from Capital Medical University. The author has contributed to research in topics: Cancer Cells and Metastasis & Prostate Cancer Treatment and Research & Cancer, Hypoxia, and Metabolism. The author has an h-index of 17, co-authored 39 publications.
ORCID: 0000-0002-4800-8832Papers by this author
worksEpithelial-Mesenchymal Transition and Migration of Prostate Cancer Stem Cells Is Driven by Cancer-Associated Fibroblasts in an HIF-1α/β-Catenin-Dependent Pathway
2013 · Molecules and Cells · 29 citations
https://doi.org/10.1007/s10059-013-0096-8
Pure retroperitoneal natural orifice translumenal endoscopic surgery (NOTES) transvaginal nephrectomy using standard laparoscopic instruments: a safety and feasibility study in a porcine model
2016 · BMC Urology · 4 citations
https://doi.org/10.1186/s12894-016-0145-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat